603168 莎普爱思
已收盘 12-20 15:00:00
资讯
新帖
简况
莎普爱思收盘上涨0.13%,最新市净率1.67
金融界 · 12-20 20:05
莎普爱思收盘上涨0.13%,最新市净率1.67
莎普爱思12月19日遭主力抛售771万元 环比增加117.18%
市场透视 · 12-19 15:19
莎普爱思12月19日遭主力抛售771万元 环比增加117.18%
莎普爱思(603168)12月17日主力资金净卖出1288.52万元
证券之星 · 12-17
莎普爱思(603168)12月17日主力资金净卖出1288.52万元
莎普爱思12月17日遭主力抛售1421万元 环比增加1676.25%
市场透视 · 12-17
莎普爱思12月17日遭主力抛售1421万元 环比增加1676.25%
莎普爱思大跌 资金净流出
智选洞察 · 12-17
莎普爱思大跌 资金净流出
莎普爱思最新公告:盐酸西替利嗪滴眼液获得临床试验批准通知书
证券之星 · 12-09
莎普爱思最新公告:盐酸西替利嗪滴眼液获得临床试验批准通知书
莎普爱思:盐酸西替利嗪滴眼液获临床试验批准
美港电讯 · 12-09
莎普爱思:盐酸西替利嗪滴眼液获临床试验批准
莎普爱思(603168.SH):盐酸西替利嗪滴眼液临床试验获批准
智通财经 · 12-09
莎普爱思(603168.SH):盐酸西替利嗪滴眼液临床试验获批准
莎普爱思12月06日遭主力抛售449万元 环比增加308.18%
市场透视 · 12-06
莎普爱思12月06日遭主力抛售449万元 环比增加308.18%
莎普爱思11月29日主力资金流出280万元 连续3日减仓
市场透视 · 11-29
莎普爱思11月29日主力资金流出280万元 连续3日减仓
莎普爱思销量下滑前三季亏3075万 陈德康套现11亿又抛2%减持计划
长江商报 · 11-26
莎普爱思销量下滑前三季亏3075万 陈德康套现11亿又抛2%减持计划
A股医药股震荡走低,天新药业、莎普爱思、微芯生物、常山药业跌超5%,广生堂、海思科、华润双鹤等跟跌。
美港电讯 · 11-22
A股医药股震荡走低,天新药业、莎普爱思、微芯生物、常山药业跌超5%,广生堂、海思科、华润双鹤等跟跌。
【机构调研记录】睿远基金调研莎普爱思
证券之星 · 11-22
【机构调研记录】睿远基金调研莎普爱思
【机构调研记录】海富通基金调研莎普爱思
证券之星 · 11-22
【机构调研记录】海富通基金调研莎普爱思
【机构调研记录】汇添富基金调研莎普爱思、杭州银行
证券之星 · 11-22
【机构调研记录】汇添富基金调研莎普爱思、杭州银行
【机构调研记录】易方达基金调研莎普爱思、长安汽车
证券之星 · 11-22
【机构调研记录】易方达基金调研莎普爱思、长安汽车
【机构调研记录】天弘基金调研莎普爱思、安必平等3只个股(附名单)
证券之星 · 11-22
【机构调研记录】天弘基金调研莎普爱思、安必平等3只个股(附名单)
11月21日上市公司减持汇总:莎普爱思等9股拟减持(表)
新浪证券 · 11-21
11月21日上市公司减持汇总:莎普爱思等9股拟减持(表)
不超5%!莎普爱思遭多股东抛大额减持计划,前三季度亏损3076万元
读创客户端 · 11-21
不超5%!莎普爱思遭多股东抛大额减持计划,前三季度亏损3076万元
莎普爱思:股东拟合计减持不超5%公司股份
证券 · 11-21
莎普爱思:股东拟合计减持不超5%公司股份
加载更多
公司概况
公司名称:
浙江莎普爱思药业股份有限公司
所属行业:
医药制造业
上市日期:
2014-07-02
主营业务:
浙江莎普爱思药业股份有限公司主营业务为医药制造板块以及医疗服务板块。主要产品为苄达赖氨酸滴眼液、大输液、头孢克肟、诊疗服务。公司核心产品莎普爱思滴眼液属于眼科用药(抗白内障类)领域。公司利用营销网络优势,为莎普爱思滴眼液树立了良好的品牌和知名度,在国内白内障药物市场中处于行业前列。根据北京东方比特科技有限公司《中国白内障滴眼液市场研究报告》数据显示,2019年公司莎普爱思滴眼液在我国白内障用药市场份额为21.51%。
发行价格:
21.85
{"stockData":{"symbol":"603168","market":"SH","secType":"STK","nameCN":"莎普爱思","latestPrice":7.47,"timestamp":1734678000000,"preClose":7.46,"halted":0,"volume":5983850,"delay":0,"floatShares":323000000,"shares":376000000,"eps":-0.2256,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"12-20 15:00:00","open":7.45,"high":7.56,"low":7.42,"amount":44858600,"amplitude":0.0188,"askPrice":7.48,"askSize":197,"bidPrice":7.47,"bidSize":92,"shortable":0,"etf":0,"ttmEps":-0.2256,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":7.46,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":8.21,"lowLimit":6.71,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":375925005,"pbRate":1.67,"roa":"--","roe":"--","epsLYR":0.07,"committee":-0.060069,"marketValue":2808000000,"floatMarketCap":2410000000,"peRate":-33.111702,"changeRate":0.0013,"turnoverRate":0.0185,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-12-23。"},"requestUrl":"/m/hq/s/603168","defaultTab":"news","newsList":[{"id":"2492121884","title":"莎普爱思收盘上涨0.13%,最新市净率1.67","url":"https://stock-news.laohu8.com/highlight/detail?id=2492121884","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492121884?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:05","pubTimestamp":1734696304,"startTime":"0","endTime":"0","summary":"12月20日,莎普爱思今日收盘7.47元,上涨0.13%,最新市净率1.67。消息面上,莎普爱思11月1日接待易方达基金等29家机构调研,上市公司接待人员包括董事会秘书黄明雄。公司核心产品莎普爱思滴眼液属于眼科用药领域。公司利用营销网络优势,为莎普爱思滴眼液树立了良好的品牌和知名度,在国内白内障药物市场中处于行业前列。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220200842a1fdc555&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220200842a1fdc555&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2492117531","title":"莎普爱思12月19日遭主力抛售771万元 环比增加117.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492117531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492117531?lang=zh_cn&edition=full","pubTime":"2024-12-19 15:19","pubTimestamp":1734592798,"startTime":"0","endTime":"0","summary":"12月19日, 莎普爱思股价跌0.67%,报收7.46元,成交金额5126万元,换手率2.15%,振幅2.80%,量比0.68。莎普爱思今日主力资金净流出771万元,连续5日净流出,上一交易日主力净流出355万元,今日环比增加117.18%。该股近5个交易日下跌11.72%,主力资金累计净流出4203万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出1.12亿元,其中净流出天数为17日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219160417a1fa9df2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219160417a1fa9df2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2492981174","title":"莎普爱思(603168)12月17日主力资金净卖出1288.52万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492981174","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492981174?lang=zh_cn&edition=full","pubTime":"2024-12-17 15:21","pubTimestamp":1734420069,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年12月17日收盘,莎普爱思报收于7.6元,下跌7.43%,换手率5.25%,成交量16.94万手,成交额1.32亿元。12月17日的资金流向数据方面,主力资金净流出1288.52万元,占总成交额9.77%,游资资金净流入920.01万元,占总成交额6.98%,散户资金净流入368.51万元,占总成交额2.8%。莎普爱思主营业务:从事药品研发、生产、销售及医疗服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121700020326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2492530969","title":"莎普爱思12月17日遭主力抛售1421万元 环比增加1676.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492530969","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492530969?lang=zh_cn&edition=full","pubTime":"2024-12-17 15:19","pubTimestamp":1734419965,"startTime":"0","endTime":"0","summary":"12月17日, 莎普爱思股价跌7.43%,报收7.60元,成交金额1.32亿元,换手率5.25%,振幅8.28%,量比2.09。莎普爱思今日主力资金净流出1421万元,连续3日净流出,上一交易日主力净流出80万元,今日环比增加1676.25%。该股近5个交易日下跌7.54%,主力资金累计净流出3166万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出7510万元,其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217153213ab7e769a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217153213ab7e769a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2492648609","title":"莎普爱思大跌 资金净流出","url":"https://stock-news.laohu8.com/highlight/detail?id=2492648609","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492648609?lang=zh_cn&edition=full","pubTime":"2024-12-17 10:25","pubTimestamp":1734402358,"startTime":"0","endTime":"0","summary":"12月17日,莎普爱思股价大幅下跌,截至10点25分,莎普爱思下跌5.24%,报7.78元/股,成交3981万元,换手率1.55%,振幅6.09%。资金动向截止发稿,莎普爱思获得主力净流出520万元,其中超大单流出500万元,大单流出19万元。主营业务及业绩莎普爱思公司主营业务为滴眼液、大输液和头孢克肟等产品的研发、生产和销售。最新财报显示,今年三季报,莎普爱思实现营业收入3.59亿元,同比减少27.95%,净利润为-3,075.54万元,同比减少138.71%,基本每股收益为-0.08元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121710261795ea20df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121710261795ea20df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2490743600","title":"莎普爱思最新公告:盐酸西替利嗪滴眼液获得临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2490743600","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490743600?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:45","pubTimestamp":1733733928,"startTime":"0","endTime":"0","summary":"莎普爱思公告,公司盐酸西替利嗪滴眼液获得国家药监局核准签发的《药物临床试验批准通知书》,公司拟于条件具备后开展临床试验。该药品适用于过敏性结膜炎伴随的眼痒的治疗。截至公告披露日,该项目累计研发投入约474.69万元人民币。药品在获得药物临床试验批准通知书后,尚需开展临床试验并经国家药监局审评、审批通过后方可生产上市。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120900021111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","603168","BK1583","BK1576","03347","BK0239"],"gpt_icon":0},{"id":"2490771054","title":"莎普爱思:盐酸西替利嗪滴眼液获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2490771054","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490771054?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:19","pubTimestamp":1733732348,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["603168","BK1141","BK1583","BK1576","BK0239","03347"],"gpt_icon":0},{"id":"2490371073","title":"莎普爱思(603168.SH):盐酸西替利嗪滴眼液临床试验获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2490371073","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490371073?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:16","pubTimestamp":1733732161,"startTime":"0","endTime":"0","summary":"智通财经APP讯,莎普爱思(603168.SH)发布公告,公司的盐酸西替利嗪滴眼液获得国家药品监督管理局核准签发的《药物临床试验批准通知书》(通知书编号:2024LP02825),公司拟于条件具备后开展临床试验。本品适用于过敏性结膜炎伴随的眼痒的治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1222103.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1583","BK1576","BK1141","603168","03347"],"gpt_icon":0},{"id":"2489286106","title":"莎普爱思12月06日遭主力抛售449万元 环比增加308.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489286106","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489286106?lang=zh_cn&edition=full","pubTime":"2024-12-06 15:18","pubTimestamp":1733469506,"startTime":"0","endTime":"0","summary":"12月06日, 莎普爱思股价涨1.24%,报收8.17元,成交金额7173万元,换手率2.74%,振幅2.48%,量比1.13。莎普爱思今日主力资金净流出449万元,连续3日净流出,上一交易日主力净流出110万元,今日环比增加308.18%。该股近5个交易日上涨2.38%,主力资金累计净流出2466万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出4222万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206152329a1d881e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206152329a1d881e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2487589444","title":"莎普爱思11月29日主力资金流出280万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2487589444","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487589444?lang=zh_cn&edition=full","pubTime":"2024-11-29 15:19","pubTimestamp":1732864770,"startTime":"0","endTime":"0","summary":"11月29日, 莎普爱思股价涨0.63%,报收7.98元,成交金额5798万元,换手率2.26%,振幅3.28%,量比0.59。莎普爱思今日主力资金净流出280万元,连续3日净流出,上一交易日主力净流出615万元,今日环比减少54.47%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为45.45%,平均跌幅为3.59%。该股近5个交易日上涨0.38%,主力资金累计净流出1584万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出4466万元,其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129152955a25e842b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129152955a25e842b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2486931300","title":"莎普爱思销量下滑前三季亏3075万 陈德康套现11亿又抛2%减持计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2486931300","media":"长江商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486931300?lang=zh_cn&edition=full","pubTime":"2024-11-26 08:27","pubTimestamp":1732580869,"startTime":"0","endTime":"0","summary":"11月24日晚间,莎普爱思披露,公司第二大股东陈德康拟在未来3个月内减持不超过公司2%的股份,另一股东拟减持不超过3%的股份。经营亏损,源于莎普爱思两大产品销量下滑。今年前三季度,公司研发投入0.45亿元,同比下降11.96%。目前,莎普爱思股东陈德康持有公司股份数量为4698.32万股,占公司总股本的 12.39%。在抛出本次减持计划前,陈德康已经累计套现11.21亿元。收购不见效前三季转亏两大股东持续减持的莎普爱思,经营业绩不佳。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126083119a2559723&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126083119a2559723&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2485408115","title":"A股医药股震荡走低,天新药业、莎普爱思、微芯生物、常山药业跌超5%,广生堂、海思科、华润双鹤等跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2485408115","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485408115?lang=zh_cn&edition=full","pubTime":"2024-11-22 10:37","pubTimestamp":1732243059,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0188","300255","BK0010","BK0033","159938","BK0077","300436","603235","BK0239","600062","002653","159982","399300","BK0185","BK1515","BK0028","BK0226","09939","688321","BK1161","603168","BK0172","BK0175","BK1574","BK0070"],"gpt_icon":0},{"id":"2485017473","title":"【机构调研记录】睿远基金调研莎普爱思","url":"https://stock-news.laohu8.com/highlight/detail?id=2485017473","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485017473?lang=zh_cn&edition=full","pubTime":"2024-11-22 08:02","pubTimestamp":1732233763,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为睿远均衡价值三年持有混合A,最新单位净值为1.33,近一年增长11.5%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200006796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2485473021","title":"【机构调研记录】海富通基金调研莎普爱思","url":"https://stock-news.laohu8.com/highlight/detail?id=2485473021","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485473021?lang=zh_cn&edition=full","pubTime":"2024-11-22 08:02","pubTimestamp":1732233761,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为海富通一年定开债A,最新单位净值为1.16,近一年增长48.01%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200006792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2485880475","title":"【机构调研记录】汇添富基金调研莎普爱思、杭州银行","url":"https://stock-news.laohu8.com/highlight/detail?id=2485880475","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485880475?lang=zh_cn&edition=full","pubTime":"2024-11-22 08:02","pubTimestamp":1732233760,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为汇添富北交所创新精选两年定开混合A,最新单位净值为1.33,近一年增长83.7%。旗下最新募集公募基金产品为汇添富中证A500指数A,类型为指数型-股票,集中认购期2024年11月13日至2024年12月6日。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200006791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600926","603168","BK0188","BK0278","BK0239","BK0187"],"gpt_icon":0},{"id":"2485473770","title":"【机构调研记录】易方达基金调研莎普爱思、长安汽车","url":"https://stock-news.laohu8.com/highlight/detail?id=2485473770","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485473770?lang=zh_cn&edition=full","pubTime":"2024-11-22 08:02","pubTimestamp":1732233759,"startTime":"0","endTime":"0","summary":"易方达基金成立于2001年,截至目前,资产管理规模19935.52亿元,排名1/208;资产管理规模12813.73亿元,排名1/208;管理公募基金数728只,排名3/208;旗下公募基金经理94人,排名5/208。旗下最近一年表现最佳的公募基金产品为易方达北交所精选两年定开混合A,最新单位净值为1.42,近一年增长72.19%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200006788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0006","BK0010","BK0239","BK0183","BK0028","BK0012","000625","BK0014","603168","BK0188","BK0264","BK0196"],"gpt_icon":0},{"id":"2485730144","title":"【机构调研记录】天弘基金调研莎普爱思、安必平等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2485730144","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485730144?lang=zh_cn&edition=full","pubTime":"2024-11-22 08:02","pubTimestamp":1732233751,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为天弘中证中美互联网A,最新单位净值为1.36,近一年增长34.8%。旗下最新募集公募基金产品为天弘价值驱动混合A,类型为混合型-偏股,集中认购期2024年10月15日至2025年1月14日。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200006775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168","688393"],"gpt_icon":0},{"id":"2485415513","title":"11月21日上市公司减持汇总:莎普爱思等9股拟减持(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2485415513","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485415513?lang=zh_cn&edition=full","pubTime":"2024-11-21 23:17","pubTimestamp":1732202220,"startTime":"0","endTime":"0","summary":"据统计,11月21日,盘后包括长光华芯、航天软件、诚达药业、莎普爱思、优博讯、宇信科技、盈方微、慧辰股份(维权)、上纬新材在内的9家A股上市公司披露减持情况。\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-21/doc-incwvyqw9730574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2485459496","title":"不超5%!莎普爱思遭多股东抛大额减持计划,前三季度亏损3076万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485459496","media":"读创客户端","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485459496?lang=zh_cn&edition=full","pubTime":"2024-11-21 21:01","pubTimestamp":1732194093,"startTime":"0","endTime":"0","summary":"财务方面,莎普爱思前三季度由盈转亏,公司实现营业收入3.59亿元,同比下降27.95%;归母净利润亏损3075.54万元,同比下降138.71%。值得一提的是,莎普爱思去年以来加大销售力度,2023年的销售费用同比增长45.09%至1.35亿元,但其核心产品的销量却没有达到预期目标。截至2024年三季度末,莎普爱思销售费用为6522.65万元,占营收比例为17.66%。二级市场上,截至21日收盘,莎普爱思涨7.07%报8.78元/股,最新市值33.29亿元,近三月累计上涨41.84%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121211537a24b5100&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121211537a24b5100&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2485672654","title":"莎普爱思:股东拟合计减持不超5%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2485672654","media":"证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485672654?lang=zh_cn&edition=full","pubTime":"2024-11-21 19:36","pubTimestamp":1732188960,"startTime":"0","endTime":"0","summary":"证券时报e公司讯,莎普爱思(603168)11月21日晚间公告,股东陈德康持有公司12.39%股份,上海景兴实业投资有限公司持有公司4.7%股份。陈德康计划减持公司股份数量合计不超过758.32万股,即不超过公司总股本的2%。上海景兴计划减持公司股份数量合计不超过1137.48万股,即不超过公司总股本的3%。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-11-21/doc-incwvpzk1357443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","603168"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2014-07-02","address":"浙江省嘉兴市平湖市经济开发区新明路1588号","stockEarnings":[{"period":"1week","weight":-0.089},{"period":"1month","weight":-0.089},{"period":"3month","weight":0.1952},{"period":"6month","weight":-0.0616},{"period":"1year","weight":-0.3324},{"period":"ytd","weight":-0.4415}],"companyName":"浙江莎普爱思药业股份有限公司","boardCode":"AI0027","perCapita":"10347股","boardName":"医药制造业","registeredCapital":"37592万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":" 浙江莎普爱思药业股份有限公司主营业务为医药制造板块以及医疗服务板块。主要产品为苄达赖氨酸滴眼液、大输液、头孢克肟、诊疗服务。公司核心产品莎普爱思滴眼液属于眼科用药(抗白内障类)领域。公司利用营销网络优势,为莎普爱思滴眼液树立了良好的品牌和知名度,在国内白内障药物市场中处于行业前列。根据北京东方比特科技有限公司《中国白内障滴眼液市场研究报告》数据显示,2019年公司莎普爱思滴眼液在我国白内障用药市场份额为21.51%。","serverTime":1734724127866,"listedPrice":21.85,"stockholders":"31175人(较上一季度减少0.92%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莎普爱思,603168,莎普爱思股票,莎普爱思股票老虎,莎普爱思股票老虎国际,莎普爱思行情,莎普爱思股票行情,莎普爱思股价,莎普爱思股市,莎普爱思股票价格,莎普爱思股票交易,莎普爱思股票购买,莎普爱思股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}